Cargando…
Critical analysis of the potential for microRNA biomarkers in breast cancer management
Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor (ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver in the development and progression of a large majority of breast tumors. Molecular characterization of primary tumors has id...
Autores principales: | Graveel, Carrie R, Calderone, Heather M, Westerhuis, Jennifer J, Winn, Mary E, Sempere, Lorenzo F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346363/ https://www.ncbi.nlm.nih.gov/pubmed/25759599 http://dx.doi.org/10.2147/BCTT.S43799 |
Ejemplares similares
-
Celebrating 25 Years of MicroRNA Research: From Discovery to Clinical Application
por: Sempere, Lorenzo F.
Publicado: (2019) -
microRNA‐based diagnostic and therapeutic applications in cancer medicine
por: Sempere, Lorenzo F., et al.
Publicado: (2021) -
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications
por: Sempere, Lorenzo F., et al.
Publicado: (2017) -
MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
por: Fernández-Villabrille, Sara, et al.
Publicado: (2023) -
Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers
por: Mar-Aguilar, Fermín, et al.
Publicado: (2013)